Walgreens Boots Alliance, Inc. vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown

Comparing Walgreens and Supernus: A Decade of Profit Trends

__timestampSupernus Pharmaceuticals, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 201411628700021569000000
Thursday, January 1, 201513600400026859000000
Friday, January 1, 201620301700029874000000
Sunday, January 1, 201728702300029162000000
Monday, January 1, 201839354100030792000000
Tuesday, January 1, 201937609500028159000000
Wednesday, January 1, 202046793800026077000000
Friday, January 1, 202150471400028067000000
Saturday, January 1, 202258001700028266000000
Sunday, January 1, 202352374200027072000000
Monday, January 1, 202426524000000
Loading chart...

Unleashing the power of data

Walgreens Boots Alliance vs. Supernus Pharmaceuticals: A Decade of Gross Profit Trends

In the ever-evolving landscape of the pharmaceutical and retail sectors, Walgreens Boots Alliance and Supernus Pharmaceuticals have showcased distinct trajectories in their gross profit performance from 2014 to 2023. Walgreens Boots Alliance, a retail giant, consistently reported gross profits exceeding $20 billion annually, peaking in 2018 with a 43% increase from 2014. Meanwhile, Supernus Pharmaceuticals, a specialty pharmaceutical company, demonstrated impressive growth, with gross profits surging by nearly 400% over the same period, reaching their zenith in 2022. This stark contrast highlights the diverse strategies and market positions of these companies. While Walgreens capitalizes on its expansive retail network, Supernus focuses on niche pharmaceutical innovations. Notably, 2024 data for Supernus is absent, leaving room for speculation on its future trajectory. This analysis underscores the dynamic nature of the industry and the varied paths to financial success.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025